Back to search
FDAFDA · Food and drugs·Recall number D-1403-2012

Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01

Published July 11, 2012 · Recall initiated: April 17, 2012

Summary

FDA records drug Class III recall D-1403-2012, published July 11, 2012 and initiated April 17, 2012. Recalling firm: Watson Laboratories Inc; Status: Terminated; Reported quantity: 7,262 bottles; Lot: Lot # 22478A. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Watson Laboratories Inc
Distributor
Nationwide.
Lot
Lot # 22478A
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01 recalled?

Yes. FDA published recall D-1403-2012 on July 11, 2012. Reported hazard: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

What should I do if I have this product?

Voluntary: Firm initiated · Letter